BioCardia (BCDA) Cash from Investing Activities Growth (1y) (2011 - 2025)
Powered by 
Analysis
BioCardia (BCDA) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | -1,435.24% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | -634.97% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 27.49% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -389.88% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 68.76% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -500.00% |
| Jun 30, 2025 | 66.67% |
| Jun 30, 2024 | -50.00% |
| Jun 30, 2023 | 92.00% |
| Mar 31, 2023 | 65.52% |
| Dec 31, 2022 | 95.12% |
| Sep 30, 2022 | 30.00% |
| Jun 30, 2022 | 10.71% |
| Mar 31, 2022 | -7.41% |
| Sep 30, 2021 | 13.04% |
| Jun 30, 2021 | -600.00% |
| Mar 31, 2021 | -440.00% |
| Sep 30, 2020 | -15.00% |
| Jun 30, 2020 | 94.20% |
| Mar 31, 2020 | 90.91% |
| Dec 31, 2019 | 86.67% |
| Sep 30, 2019 | -300.00% |
| Jun 30, 2019 | -68.29% |
| Mar 31, 2019 | -1,000.00% |
| Dec 31, 2018 | -100.85% |